{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:30:06Z","timestamp":1775241006623,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.ppat.1010689","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000}}],"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108072"],"award-info":[{"award-number":["JP20fk0108072"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108080"],"award-info":[{"award-number":["JP21fk0108080"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108114"],"award-info":[{"award-number":["JP21fk0108114"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fm0208101"],"award-info":[{"award-number":["JP21fm0208101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Favipiravir is a nucleoside analogue that inhibits the replication and transcription of a broad spectrum of RNA viruses, including pathogenic arenaviruses. In this study, we isolated a favipiravir-resistant mutant of Junin virus (JUNV), which is the causative agent of Argentine hemorrhagic fever, and analyzed the antiviral mechanism of favipiravir against JUNV. Two amino acid substitutions, N462D in the RNA-dependent RNA polymerase (RdRp) and A168T in the glycoprotein precursor GPC, were identified in the mutant. GPC-A168T substitution enhanced the efficiency of JUNV internalization, which explains the robust replication kinetics of the mutant in the virus growth analysis. Although RdRp-N462D substitution did not affect polymerase activity levels in a minigenome system, comparisons of RdRp error frequencies showed that the virus with RdRp-D462 possessed a significantly higher fidelity. Our next generation sequence (NGS) analysis showed a gradual accumulation of both mutations as we passaged the virus in presence of favipiravir. We also provided experimental evidence for the first time that favipiravir inhibited JUNV through the accumulation of transition mutations, confirming its role as a purine analogue against arenaviruses. Moreover, we showed that treatment with a combination of favipiravir and either ribavirin or remdesivir inhibited JUNV replication in a synergistic manner, blocking the generation of the drug-resistant mutant. Our findings provide new insights for the clinical management and treatment of Argentine hemorrhagic fever.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010689","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T13:34:18Z","timestamp":1657546458000},"page":"e1010689","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Potential and action mechanism of favipiravir as an antiviral against Junin virus"],"prefix":"10.1371","volume":"18","author":[{"given":"Vahid Rajabali","family":"Zadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tosin Oladipo","family":"Afowowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-5621","authenticated-orcid":true,"given":"Jiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"ppat.1010689.ref001","unstructured":"NIAID Emerging Infectious Diseases\/Pathogens | NIH: National Institute of Allergy and Infectious Diseases [Internet]. [cited 2018 Nov 24]. Available from: https:\/\/www.niaid.nih.gov\/research\/emerging-infectious-diseases-pathogens"},{"issue":"18","key":"ppat.1010689.ref002","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"L Borio","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"ppat.1010689.ref003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"DA Enria","year":"2008","journal-title":"Antiviral Res"},{"key":"ppat.1010689.ref004","author":"I Veliziotis","journal-title":"Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020\u2014Volume 26, Number 7\u2014July 2020\u2014Emerging Infectious Diseases journal\u2014CDC"},{"issue":"16","key":"ppat.1010689.ref005","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1073\/pnas.1600996113","article-title":"Monoclonal antibody therapy for Junin virus infection","volume":"113","author":"L Zeitlin","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1010689.ref006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4269\/ajtmh.1993.48.403","article-title":"Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques","volume":"48","author":"KT McKee","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"ppat.1010689.ref007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/138920291407131220153526","article-title":"Watching Every Step of the Way: Jun\u00edn Virus Attenuation Markers in the Vaccine Lineage","volume":"14","author":"BI Stephan","year":"2013","journal-title":"Curr Genomics"},{"key":"ppat.1010689.ref008","article-title":"Second-generation live-attenuated Candid#1 vaccine virus resists reversion and protects against lethal Jun\u00edn virus infection in guinea pigs","author":"BB Gowen","year":"2021","journal-title":"J Virol [Internet]"},{"key":"ppat.1010689.ref009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"L Delang","year":"2018","journal-title":"Antiviral Res"},{"issue":"3","key":"ppat.1010689.ref010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Y Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ppat.1010689.ref011","first-page":"e01217","article-title":"Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing. Garc\u00eda-Sastre A, editor","volume":"93","author":"DH Goldhill","year":"2018","journal-title":"J Virol"},{"issue":"7","key":"ppat.1010689.ref012","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/nar\/gkg277","article-title":"A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases","volume":"31","author":"JA Bruenn","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ppat.1010689.ref013","doi-asserted-by":"crossref","first-page":"e0009103","DOI":"10.1371\/journal.pntd.0009103","article-title":"A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"K Suemori","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"key":"ppat.1010689.ref014","article-title":"Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses","author":"V Madelain","year":"2017","journal-title":"Antimicrob Agents Chemother [Internet]"},{"issue":"3","key":"ppat.1010689.ref015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmv.1890200308","article-title":"Therapeutic Effect of the Antiviral Agent Ribavirin in Junin Virus Infection of Primates","volume":"20","author":"MC Weissenbacher","year":"1986","journal-title":"J Med Virol"},{"issue":"12","key":"ppat.1010689.ref016","doi-asserted-by":"crossref","first-page":"e2614","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) Inhibits Jun\u00edn Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever","volume":"7","author":"BB Gowen","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"ppat.1010689.ref017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2017.07.019","article-title":"Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy","volume":"145","author":"BB Gowen","year":"2017","journal-title":"Antiviral Res"},{"issue":"3","key":"ppat.1010689.ref018","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.29.3.521","article-title":"Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs","volume":"29","author":"RH Kenyon","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ppat.1010689.ref019","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.32.9.1304","article-title":"Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever","volume":"32","author":"KT McKee","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1010689.ref020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.12.006","article-title":"Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses","volume":"126","author":"JB Westover","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"ppat.1010689.ref021","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1038\/s41598-017-10198-0","article-title":"Determining Ribavirin\u2019s mechanism of action against Lassa virus infection","volume":"7","author":"P Carrillo-Bustamante","year":"2017","journal-title":"Sci Rep."},{"issue":"10","key":"ppat.1010689.ref022","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"L Delang","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"ppat.1010689.ref023","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/AAC.01073-16","article-title":"In Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71","volume":"60","author":"Y Wang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"45","key":"ppat.1010689.ref024","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"DH Goldhill","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"43","key":"ppat.1010689.ref025","doi-asserted-by":"crossref","first-page":"26946","DOI":"10.1073\/pnas.2012294117","article-title":"Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases","volume":"117","author":"MK Lo","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"ppat.1010689.ref026","doi-asserted-by":"crossref","first-page":"e1342","DOI":"10.1371\/journal.pntd.0001342","article-title":"Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever","volume":"5","author":"M Mendenhall","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"issue":"9","key":"ppat.1010689.ref027","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections","volume":"51","author":"BB Gowen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Supplement_4","key":"ppat.1010689.ref028","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1093\/infdis\/jiz564","article-title":"Inhibition of Nipah Virus by Defective Interfering Particles","volume":"11;221","author":"SR Welch","year":"2020","journal-title":"J Infect Dis"},{"issue":"7","key":"ppat.1010689.ref029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tim.2020.02.006","article-title":"Defective Interfering Particles of Negative-Strand RNA Viruses","volume":"28","author":"CM Ziegler","year":"2020","journal-title":"Trends Microbiol"},{"issue":"7800","key":"ppat.1010689.ref030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-020-2114-2","article-title":"Structural insight into arenavirus replication machinery","volume":"579","author":"R Peng","year":"2020","journal-title":"Nature"},{"issue":"1","key":"ppat.1010689.ref031","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/JVI.00721-10","article-title":"Domain Structure of Lassa Virus L Protein","volume":"85","author":"L Brunotte","year":"2011","journal-title":"J Virol"},{"issue":"52","key":"ppat.1010689.ref032","first-page":"2953","article-title":"Isolation of fidelity variants of RNA viruses and characterization of virus mutation frequency","author":"S Beaucourt","year":"2011","journal-title":"J Vis Exp JoVE"},{"key":"ppat.1010689.ref033","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/82_2015_468","article-title":"Arenavirus Quasispecies and Their Biological Implications","volume":"392","author":"A Grande-P\u00e9rez","year":"2015","journal-title":"Quasispecies Theory Exp Syst."},{"issue":"8","key":"ppat.1010689.ref034","doi-asserted-by":"crossref","first-page":"e3000003","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"S. Duffy","year":"2018","journal-title":"PLoS Biol"},{"issue":"12","key":"ppat.1010689.ref035","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: Direct molecular test by using ribavirin","volume":"98","author":"S Crotty","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"ppat.1010689.ref036","first-page":"3","article-title":"Favipiravir elicits antiviral mutagenesis during virus replication in vivo","author":"A Arias","year":"2014","journal-title":"eLife [Internet]"},{"issue":"9","key":"ppat.1010689.ref037","article-title":"Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs","volume":"62","author":"MR Bassi","year":"2018","journal-title":"Antimicrob Agents Chemother [Internet]"},{"issue":"8","key":"ppat.1010689.ref038","first-page":"e00669","article-title":"Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir","volume":"63","author":"B Borrego","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ppat.1010689.ref039","doi-asserted-by":"crossref","first-page":"e1002535","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques","volume":"15","author":"J Guedj","year":"2018","journal-title":"PLOS Med."},{"issue":"10","key":"ppat.1010689.ref040","first-page":"e0164691","volume":"11","author":"AI de \u00c1vila","year":"2016","journal-title":"Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir. PLOS ONE"},{"issue":"2","key":"ppat.1010689.ref041","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture","volume":"55","author":"M Mendenhall","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1010689.ref042","doi-asserted-by":"crossref","first-page":"104529","DOI":"10.1016\/j.antiviral.2019.06.001","article-title":"T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques","volume":"170","author":"N Espy","year":"2019","journal-title":"Antiviral Res"},{"issue":"12","key":"ppat.1010689.ref043","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.0408871102","article-title":"Suppression of viral infectivity through lethal defection","volume":"102","author":"A Grande-P\u00e9rez","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"16","key":"ppat.1010689.ref044","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1128\/JVI.79.16.10451-10459.2005","article-title":"Mutagenesis-Induced, Large Fitness Variations with an Invariant Arenavirus Consensus Genomic Nucleotide Sequence","volume":"79","author":"A Grande-P\u00e9rez","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"ppat.1010689.ref045","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/JVI.03483-14","article-title":"Effective Lethal Mutagenesis of Influenza Virus by Three Nucleoside Analogs","volume":"89","author":"MD Pauly","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"ppat.1010689.ref046","first-page":"1","article-title":"Generation and characterization of influenza A viruses with altered polymerase fidelity","volume":"5","author":"PPH Cheung","year":"2014","journal-title":"Nat Commun."},{"issue":"12","key":"ppat.1010689.ref047","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity","volume":"100","author":"JK Pfeiffer","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"7053","key":"ppat.1010689.ref048","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"JJ Feld","year":"2005","journal-title":"Nature"},{"key":"ppat.1010689.ref049","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","author":"EP Tchesnokov","year":"2020","journal-title":"J Biol Chem"},{"issue":"3","key":"ppat.1010689.ref050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/JVI.02139-12","article-title":"Ribavirin-Resistant Mutants of Human Enterovirus 71 Express a High Replication Fidelity Phenotype during Growth in Cell Culture","volume":"87","author":"S Sadeghipour","year":"2013","journal-title":"J Virol"},{"issue":"7074","key":"ppat.1010689.ref051","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"M Vignuzzi","year":"2006","journal-title":"Nature"},{"issue":"2","key":"ppat.1010689.ref052","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.ppat.0010011","article-title":"Increased Fidelity Reduces Poliovirus Fitness and Virulence under Selective Pressure in Mice","volume":"1","author":"JK Pfeiffer","year":"2005","journal-title":"PLOS Pathog."},{"issue":"10","key":"ppat.1010689.ref053","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/v4102049","article-title":"Molecular Mechanism of Arenavirus Assembly and Budding","volume":"4","author":"S Urata","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"ppat.1010689.ref054","first-page":"e01682","article-title":"Epistastic Interactions within the Jun\u00edn Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1","volume":"92","author":"J York","year":"2017","journal-title":"Vaccine. J Virol"},{"key":"ppat.1010689.ref055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcimb.2017.00020","article-title":"Absence of an N-Linked Glycosylation Motif in the Glycoprotein of the Live-Attenuated Argentine Hemorrhagic Fever Vaccine, Candid #1, Results in Its Improper Processing, and Reduced Surface Expression","volume":"7","author":"JT Manning","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"issue":"3","key":"ppat.1010689.ref056","doi-asserted-by":"crossref","first-page":"e1009356","DOI":"10.1371\/journal.ppat.1009356","article-title":"Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity","volume":"17","author":"T Koma","year":"2021","journal-title":"PLOS Pathog."},{"issue":"24","key":"ppat.1010689.ref057","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1128\/JVI.05616-11","article-title":"Substitutions in the Glycoprotein (GP) of the Candid#1 Vaccine Strain of Junin Virus Increase Dependence on Human Transferrin Receptor 1 for Entry and Destabilize the Metastable Conformation of GP","volume":"85","author":"ME Droniou-Bonzom","year":"2011","journal-title":"J Virol"},{"issue":"2","key":"ppat.1010689.ref058","doi-asserted-by":"crossref","first-page":"e1005947","DOI":"10.1371\/journal.pcbi.1005947","article-title":"Life cycle synchronization is a viral drug resistance mechanism","volume":"14","author":"IA Neagu","year":"2018","journal-title":"PLOS Comput Biol."},{"key":"ppat.1010689.ref059","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1745-6150-6-42","article-title":"Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy","volume":"6","author":"AR Sedaghat","year":"2011","journal-title":"Biol Direct."},{"key":"ppat.1010689.ref060","article-title":"In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2","author":"AM Szemiel","year":"2021","journal-title":"bioRxiv."},{"issue":"9","key":"ppat.1010689.ref061","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3201\/eid2409.180233","article-title":"Use of Favipiravir to Treat Lassa Virus Infection in Macaques","volume":"24","author":"K Rosenke","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ppat.1010689.ref062","doi-asserted-by":"crossref","first-page":"e1008535","DOI":"10.1371\/journal.pcbi.1008535","article-title":"Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin","volume":"17","author":"G Lingas","year":"2021","journal-title":"PLOS Comput Biol."},{"issue":"4","key":"ppat.1010689.ref063","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from Cloned cDNAs and In Vivo Characterization of Recombinant Pathogenic Romero and Live-Attenuated Candid #1 Strains of Junin Virus, the Causative Agent of Argentine Hemorrhagic Fever Disease","volume":"85","author":"SF Emonet","year":"2011","journal-title":"J Virol"},{"key":"ppat.1010689.ref064","article-title":"Human BST-2\/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein","author":"VR Zadeh","year":"2020","journal-title":"J Gen Virol [Internet]"},{"issue":"11","key":"ppat.1010689.ref065","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jvh.13348","article-title":"First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa","volume":"27","author":"H Abe","year":"2020","journal-title":"J Viral Hepat"},{"issue":"2","key":"ppat.1010689.ref066","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1099\/jgv.0.000999","article-title":"Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species","volume":"99","author":"Y Kurosaki","year":"2018","journal-title":"J Gen Virol"},{"key":"ppat.1010689.ref067","article-title":"Identification of potential novel hosts and the risk of infection of lymphocytic choriomeningitis virus in humans in Gabon, Central Africa","author":"Y Ushijima","year":"2021","journal-title":"Int J Infect Dis [Internet]"},{"issue":"7364","key":"ppat.1010689.ref068","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann\u2013Pick C1","volume":"477","author":"JE Carette","year":"2011","journal-title":"Nature"},{"key":"ppat.1010689.ref069","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jviromet.2019.04.010","article-title":"Development of an RT-LAMP assay for the detection of Lassa viruses in southeast and south-central Nigeria","volume":"269","author":"CM Pemba","year":"2019","journal-title":"J Virol Methods"},{"issue":"2","key":"ppat.1010689.ref070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.virol.2011.01.013","article-title":"Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies","volume":"411","author":"SE Emonet","year":"2011","journal-title":"Virology"},{"issue":"16","key":"ppat.1010689.ref071","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"G Neumann","year":"1999","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"ppat.1010689.ref072","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/2211-5463.13153","article-title":"iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility","volume":"11","author":"K Imamura","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"W1","key":"ppat.1010689.ref073","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"A Ianevski","year":"2020","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1010689","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T14:08:20Z","timestamp":1658412500000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010689"}},"subtitle":[],"editor":[{"given":"Amy L.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010689","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.14.472716","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]}}}